Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explants.

IF 7.6 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
David Meier, Anish Nigade, Althea Lai, Kyle Dorman, Hacina Gill, Shahnaz Javani, Mariama Akodad, David A Wood, Toby Rogers, Rishi Puri, Keith B Allen, Adnan K Chhatriwalla, Michael J Reardon, Gilbert H L Tang, Vinayak N Bapat, John G Webb, Shinichi Fukuhara, Stephanie L Sellers
{"title":"Redo-TAVI with the SAPIEN 3 valve in degenerated calcified CoreValve/Evolut explants.","authors":"David Meier, Anish Nigade, Althea Lai, Kyle Dorman, Hacina Gill, Shahnaz Javani, Mariama Akodad, David A Wood, Toby Rogers, Rishi Puri, Keith B Allen, Adnan K Chhatriwalla, Michael J Reardon, Gilbert H L Tang, Vinayak N Bapat, John G Webb, Shinichi Fukuhara, Stephanie L Sellers","doi":"10.4244/EIJ-D-24-00619","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Redo-transcatheter aortic valve implantation (TAVI) is the treatment of choice for failed transcatheter aortic valves. Currently, implantation of a SAPIEN 3 (S3) is indicated for redo-TAVI in degenerated CoreValve/Evolut (CV/EV) transcatheter aortic valves (TAVs) but is not well understood.</p><p><strong>Aims: </strong>We aimed to evaluate S3 function following implantation in explanted calcified CV/EV TAVs and to assess the impact of CV/EV pathology on redo-TAVI outcomes.</p><p><strong>Methods: </strong>Ex vivo hydrodynamic testing was performed per the International Organization for Standardization (ISO) 5840-3 standard on 4 S3 TAVs implanted at node 5 in calcified CV/EV explants. The mean gradient (MG), effective orifice area (EOA), peak velocity, regurgitant fraction (RF), geometric orifice area (GOA), leaflet overhang, leaflet pinwheeling, neoskirt height, and frame deformation were evaluated.</p><p><strong>Results: </strong>CV/EV explants were calcified and stenotic. Following S3 implantation, the MG and peak velocity decreased. As per the ISO standard, all S3 implants showed adequate EOA, and 3 out of 4 had an RF within the accepted value (<20%). CV/EV leaflet overhang ranged from 25-37%. Calcified leaflets remained stationary throughout the cardiac cycle (difference <9%) and were not pinned in a manner that constrained S3 systolic flow or appeared to prevent selective frame cannulation. The downstream CV/EV GOA was larger than the upstream S3 GOA during systole. S3 frame underexpansion was seen, resulting in leaflet pinwheeling (range 13-30%). Above the neoskirt, calcium protrusion was observed in contact with the S3 leaflets.</p><p><strong>Conclusions: </strong>S3 implantation at node 5 in calcified CV/EV valves resulted in satisfactory hydrodynamic performance in most configurations tested with stable leaflet overhang throughout the cardiac cycle. The long-term implications of S3 underexpansion, leaflet pinwheeling, and calcium protrusion require future studies.</p>","PeriodicalId":54378,"journal":{"name":"Eurointervention","volume":"20 22","pages":"1390-1404"},"PeriodicalIF":7.6000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556406/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurointervention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4244/EIJ-D-24-00619","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Redo-transcatheter aortic valve implantation (TAVI) is the treatment of choice for failed transcatheter aortic valves. Currently, implantation of a SAPIEN 3 (S3) is indicated for redo-TAVI in degenerated CoreValve/Evolut (CV/EV) transcatheter aortic valves (TAVs) but is not well understood.

Aims: We aimed to evaluate S3 function following implantation in explanted calcified CV/EV TAVs and to assess the impact of CV/EV pathology on redo-TAVI outcomes.

Methods: Ex vivo hydrodynamic testing was performed per the International Organization for Standardization (ISO) 5840-3 standard on 4 S3 TAVs implanted at node 5 in calcified CV/EV explants. The mean gradient (MG), effective orifice area (EOA), peak velocity, regurgitant fraction (RF), geometric orifice area (GOA), leaflet overhang, leaflet pinwheeling, neoskirt height, and frame deformation were evaluated.

Results: CV/EV explants were calcified and stenotic. Following S3 implantation, the MG and peak velocity decreased. As per the ISO standard, all S3 implants showed adequate EOA, and 3 out of 4 had an RF within the accepted value (<20%). CV/EV leaflet overhang ranged from 25-37%. Calcified leaflets remained stationary throughout the cardiac cycle (difference <9%) and were not pinned in a manner that constrained S3 systolic flow or appeared to prevent selective frame cannulation. The downstream CV/EV GOA was larger than the upstream S3 GOA during systole. S3 frame underexpansion was seen, resulting in leaflet pinwheeling (range 13-30%). Above the neoskirt, calcium protrusion was observed in contact with the S3 leaflets.

Conclusions: S3 implantation at node 5 in calcified CV/EV valves resulted in satisfactory hydrodynamic performance in most configurations tested with stable leaflet overhang throughout the cardiac cycle. The long-term implications of S3 underexpansion, leaflet pinwheeling, and calcium protrusion require future studies.

使用 SAPIEN 3 瓣膜对退行性钙化的 CoreValve/Evolut 外植体进行 Redo-TAVI。
背景:重做经导管主动脉瓣植入术(TAVI)是治疗失败的经导管主动脉瓣的首选方法。目前,SAPIEN 3(S3)植入术适用于变性的CoreValve/Evolut(CV/EV)经导管主动脉瓣(TAV)的再TAVI,但人们对它的了解并不多:根据国际标准化组织(ISO)5840-3标准,对植入钙化CV/EV第5节点的4个S3 TAV进行了体外流体力学测试。对平均梯度(MG)、有效孔面积(EOA)、峰值速度、反流分数(RF)、几何孔面积(GOA)、瓣叶悬垂、瓣叶针轮、新裙高度和框架变形进行了评估:结果:CV/EV外植体钙化、狭窄。植入 S3 后,MG 和峰值速度下降。根据 ISO 标准,所有 S3 植入体都显示出足够的 EOA,4 个中有 3 个的 RF 值在可接受的范围内(结论:S3 植入体在结节处钙化后,其 MG 和峰值速度均有所下降:在钙化的 CV/EV 瓣膜的第 5 节点植入 S3 后,在测试的大多数配置中都能获得令人满意的流体力学性能,并且在整个心动周期中都能保持稳定的瓣叶悬垂。S3扩张不足、瓣叶针轮和钙突的长期影响还需要进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Eurointervention
Eurointervention CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
10.30
自引率
4.80%
发文量
380
审稿时长
3-8 weeks
期刊介绍: EuroIntervention Journal is an international, English language, peer-reviewed journal whose aim is to create a community of high quality research and education in the field of percutaneous and surgical cardiovascular interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信